The notices it replaced
- Reissues: PAR-22-128 NEI Clinical Research Study Planning Grant Program (R34 Clinical Trial Not Allowed)
- 2 steps back: PAR-19-231 NEI Clinical Research Study Planning Grant Program (R34 Clinical Trial Not Allowed)
Who won it before
10 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,107,808 in first-year total cost, median $266,421.
Most frequent study sections
- Special Emphasis Panel[ZEY1 VSN (01)]10
Most frequent institutions
- OHIO STATE UNIVERSITY3
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO3
- JOHNS HOPKINS UNIVERSITY1
- LEGACY EMANUEL HOSPITAL AND HEALTH CENTER1
- STANFORD UNIVERSITY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Decentralized Dry Eye Study, Planning & Feasibility1R34EY037743-01 · under PAR-22-128 | SEITZMAN, GERAMI D | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $492,000 | ZEY1 |
| 2024 | Designing a Pragmatic Registry-based Randomized Controlled Trial for Open-Angle Glaucoma Treatment in the US1R34EY036161-01 · under PAR-22-128 | SUN, CATHERINE QING | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $491,429 | ZEY1 |
| 2024 | Identification of School-age Eye conditions Evaluation (ISEE)1R34EY035783-01 · under PAR-22-128 | CINER, ELISE BCOLLINS, MEGAN EKULP, MARJEAN TYING, GUI-SHUANG | OHIO STATE UNIVERSITY, OH | $267,006 | ZEY1 |
| 2024 | Feasibility Studies for the Future Mediterranean Glucose Lowering Dietfor Vision Extension in AMD (M-GLOVE-AMD)1R34EY035782-01 · under PAR-22-128 | HARTNETT, MARY ELIZABETH RUTH | STANFORD UNIVERSITY, CA | $265,835 | ZEY1 |
| 2023 | Planning the VICTORY (VIsual ComplicaTions Of PrematuRitY) Study1R34EY034969-01 · under PAR-22-128 | DAMMANN, OLAF | TUFTS UNIVERSITY BOSTON, MA | $313,034 | ZEY1 |
| 2022 | Feasibility of study to delay myopia onset1R34EY033395-01A1 · under PAR-19-231 | BERNTSEN, DAVID AWALLINE, JEFFREY JAY | OHIO STATE UNIVERSITY, OH | $249,797 | ZEY1 |
| 2021 | 80 Years and Older Vision & Hearing Important Persons Project (80VIP)1R34EY031427-01A1 · under PAR-19-231 | MANSBERGER, STEVEN L | LEGACY EMANUEL HOSPITAL AND HEALTH CENTER, OR | $252,345 | ZEY1 |
| 2020 | Vision disorders in adolescents following concussion1R34EY030582-01A1 · under PAR-19-231 | JORDAN, LISA AROBERTS, TAWNA | OHIO STATE UNIVERSITY, OH | $294,281 | ZEY1 |
| 2020 | Planning study for a phase-2 randomized multi-center placebo-controlled treatment trial of retinitis pigmentosa1R34EY031429-01 · under PAR-19-231 | CAMPOCHIARO, PETER AKONG, XIANGRONG | JOHNS HOPKINS UNIVERSITY, MD | $245,625 | ZEY1 |
| 2020 | Oral metformin for non-neovascular age-related macular degeneration1R34EY031719-01 · under PAR-19-231 | STEWART, JAY MICHAEL | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $236,456 | ZEY1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.